Drugs / Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)
Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01125527 Comparator | Aug → Oct 2009 | haemophilus infectious disease | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01125527 ↗ |
| Modality | Vaccine | “Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine” NCT01125527 ↗ |